Attached files
| file | filename |
|---|---|
| 10-K - ACURA PHARMACEUTICALS, INC | v175435_10k.htm |
| EX-31.1 - ACURA PHARMACEUTICALS, INC | v175435_ex31-1.htm |
| EX-31.2 - ACURA PHARMACEUTICALS, INC | v175435_ex31-2.htm |
| EX-10.30 - ACURA PHARMACEUTICALS, INC | v175435_ex10-30.htm |
EXHIBIT
32
CERTIFICATION
OF
CHIEF
EXECUTIVE OFFICER
AND
CHIEF
FINANCIAL OFFICER
PURSUANT
TO 18 U.S.C. SECTION 1350
AS ADOPTED PURSUANT TO
SECTION
906 OF THE SARBANES-OXLEY ACT OF 2002
I, Andrew
D. Reddick, certify, pursuant to 18 U.S.C. 1350, as adopted pursuant to Section
906 of the Sarbanes-Oxley Act of 2002, that the Annual Report on Form 10-K of
Acura Pharmaceuticals, Inc. for the fiscal year ended December 31, 2009 fully
complies with the requirements of Section 13(a) or 15(d) of the Securities
Exchange Act of 1934 and that information contained in such Annual Report of
Form 10K fairly presents, in all material respects, the financial condition and
results of operations of Acura Pharmaceuticals, Inc.
|
March
2, 2010
|
By:
|
/s/Andrew
D. Reddick
|
|
Andrew
D. Reddick
|
||
|
President
and Chief Executive Officer
|
I, Peter
A. Clemens, certify, pursuant to 18 U.S.C. 1350, as adopted pursuant to Section
906 of the Sarbanes-Oxley Act of 2002, that the Annual Report on Form 10-K of
Acura Pharmaceuticals, Inc. for the fiscal year ended December 31, 2009 fully
complies with the requirements of Section 13(a) or 15(d) of the Securities
Exchange Act of 1934 and that information contained in such Annual Report of
Form 10K fairly presents, in all material respects, the financial condition and
results of operations of Acura Pharmaceuticals, Inc.
|
March
2, 2010
|
By:
|
/s/Peter
A. Clemens
|
|
Peter
A. Clemens
|
||
|
Senior
Vice President and Chief Financial
Officer
|